GWM Advisors LLC lifted its stake in shares of Cooper Companies Inc (NYSE:COO) by 7.8% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,204 shares of the medical device company’s stock after buying an additional 87 shares during the quarter. GWM Advisors LLC’s holdings in Cooper Companies were worth $406,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Comerica Securities Inc. lifted its position in shares of Cooper Companies by 5.6% in the 4th quarter. Comerica Securities Inc. now owns 903 shares of the medical device company’s stock worth $230,000 after acquiring an additional 48 shares during the period. Geode Capital Management LLC lifted its position in shares of Cooper Companies by 9.7% during the 4th quarter. Geode Capital Management LLC now owns 721,796 shares of the medical device company’s stock worth $183,414,000 after buying an additional 63,889 shares during the period. Virtu Financial LLC bought a new position in shares of Cooper Companies during the 1st quarter worth approximately $318,000. Strs Ohio lifted its position in shares of Cooper Companies by 4.1% during the 1st quarter. Strs Ohio now owns 11,505 shares of the medical device company’s stock worth $3,407,000 after buying an additional 458 shares during the period. Finally, Conning Inc. bought a new position in shares of Cooper Companies during the 1st quarter worth approximately $234,000. Institutional investors own 96.59% of the company’s stock.
Several research firms recently commented on COO. Zacks Investment Research upgraded Cooper Companies from a “hold” rating to a “buy” rating and set a $336.00 target price for the company in a research report on Friday, June 7th. Piper Jaffray Companies raised their target price on Cooper Companies from $330.00 to $360.00 and gave the stock an “overweight” rating in a research report on Tuesday, August 13th. Wells Fargo & Co raised their target price on Cooper Companies from $356.00 to $365.00 and gave the stock an “outperform” rating in a research report on Thursday, August 8th. Northcoast Research restated a “buy” rating and set a $340.00 target price (up previously from $331.00) on shares of Cooper Companies in a research report on Monday, June 3rd. Finally, Raymond James raised their target price on Cooper Companies from $325.00 to $364.00 and gave the stock an “outperform” rating in a research report on Tuesday, July 2nd. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and eleven have issued a buy rating to the company. Cooper Companies currently has an average rating of “Buy” and a consensus target price of $326.27.
Cooper Companies stock opened at $329.82 on Friday. The business has a 50 day simple moving average of $333.95 and a 200 day simple moving average of $305.82. Cooper Companies Inc has a one year low of $228.65 and a one year high of $344.32. The company has a market capitalization of $16.45 billion, a PE ratio of 28.68, a price-to-earnings-growth ratio of 2.52 and a beta of 0.90. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.21 and a quick ratio of 0.68.
Cooper Companies (NYSE:COO) last released its quarterly earnings results on Thursday, May 30th. The medical device company reported $2.94 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.76 by $0.18. Cooper Companies had a return on equity of 17.25% and a net margin of 16.46%. The firm had revenue of $654.30 million during the quarter, compared to analysts’ expectations of $655.00 million. During the same period last year, the firm posted $2.86 EPS. The business’s revenue was up 3.6% on a year-over-year basis. Equities analysts anticipate that Cooper Companies Inc will post 12.28 earnings per share for the current fiscal year.
The firm also recently declared a Semi-Annual dividend, which was paid on Wednesday, August 7th. Investors of record on Tuesday, July 23rd were issued a dividend of $0.03 per share. The ex-dividend date of this dividend was Monday, July 22nd. Cooper Companies’s dividend payout ratio is 0.52%.
Cooper Companies Profile
The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.
Featured Article: How to invest in a bear market
Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies Inc (NYSE:COO).
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.